Indrayani Biotech Ltd.BSE: INDRANIB

Indrayani Biotech Ltd. Press Release Dec 17 2024

· Issued by Indrayani Biotech Ltd. via BSE India

Filed with BSE ·

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 16, 2024 for Swaminathan

View Attachment

6ix hasn’t read this filing yet.

Indrayani Biotech Ltd. on 6ix

Story so far

Earlier from Indrayani Biotech

Later from Indrayani Biotech

All Indrayani Biotech news releases